No Data
No Data
Tracking of Hong Kong stock concepts | The Medical Insurance Bureau has announced the new medical insurance catalog. Institutions believe that the golden opportunity to increase the allocation of the pharmaceutical sector has already opened (including con
The National Medical Insurance Bureau has conducted preliminary reviews on 440 pharmaceuticals for this year's medical insurance catalog, which is an increase from last year.
Zhitoon Hong Kong Stocks Analysis | Calm on the Surface, but Strong Undercurrents Are Surging. The Market Explores the Potential of Consumerism.
The Hong Kong stock market continues to perform steadily, up 0.08%.
Shandong Xinhua Pharmaceutical (00719.HK) held a board of directors meeting on August 22 to review and approve mid-year results.
Shandong Xinhua Pharmaceutical (00719.HK) announced that it will hold a board of directors meeting at 9:30am on August 22, 2024 (Thursday) in the company meeting room at No. 1 Lutai Avenue, High-tech Zone, Zibo City, Shandong Province, China. The agenda of the meeting is as follows: 1. Review and approve the unaudited interim performance of the company and its subsidiaries for the six months ended June 30, 2024; and 2. Any other business that may arise.
SHANDONG XINHUA: Announcement Notice of Board Meeting
Some pharmaceutical stocks are rising against the market, and Beigene (06160) is up 5.03%. Institutions point to the pharmaceutical sector entering a value investment range.
Some pharmaceutical stocks bucked the trend, with BeiGene (06160) rising 5.03%, Shandong Xinhua Pharmaceutical (00719) rising 3.61%, Hansoh Pharma (03692) rising 2.38%, Joinn Laboratories (06127) rising 2.22%, and CanSinoBio (06185) rising 1.59%. News-wise, China International Capital Corporation released research reports stating that after 3 years of systematic adjustments, the pharmaceutical sector has entered the value investment range. Along with the gradual stabilization of domestic policies and the introduction of policies related to innovative drugs, the domestic innovative drug industry chain and overseas expansion are worth paying attention to in the second half of 2024.
Hong Kong stock concept tracking | Overseas giant BASF stops production, domestic vitamin industry prosperity is on the rise (attached to concept stocks).
On August 7th, global chemical giant BASFY.US announced that due to a fire in a unit at the Ludwigshafen base in Germany on July 29th, the supply of some vitamins A, vitamins E, carotenoid products and some aroma raw materials products were impacted by force majeure.
No Data
whqqq : Will more capital flow into the Hong Kong market after the delisting crisis?
HopelessChi whqqq : future is solid red. must be some amazing news crashing the future of HSI/HST
whqqq HopelessChi : What's the bad news?
海纳百川 whqqq : It will take longer for the market to recover; currently, it is still mainly bearish
whqqq 海纳百川 : OKAY...Thank you for your answer![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)